RACHEL DENEVE: Open Payments
NPI 1336918556 · SMYRNA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 21 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $191 |
| Verona Pharma, Inc. | 3 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Insmed, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| ABIOMED | 1 | $18 |
| GENZYME CORPORATION | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: OFEV, Ohtuvayre, JASCAYD, BREZTRI, Arikayce, GLASSIA, TRELEGY ELLIPTA, REXULTI.
Industry payments across TN — which companies pay providers there.
